Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel Using the Bat 24 Regimen Versus Daily and Pericoital Dosing.
Phase of Trial: Phase I
Latest Information Update: 18 Dec 2013
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors CONRAD
- 18 Dec 2013 Actual Planned End Date changed to 1 May 2013.
- 18 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.